Fingolimod

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple SclerosisNCT07220252TGTXPhase 2, Phase 3Recruiting2030-01-01Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.